ES2955282T3 - Proceso para preparar un lisado de plaquetas humanas combinadas y su uso para el tratamiento de trastornos neurológicos - Google Patents
Proceso para preparar un lisado de plaquetas humanas combinadas y su uso para el tratamiento de trastornos neurológicos Download PDFInfo
- Publication number
- ES2955282T3 ES2955282T3 ES18732057T ES18732057T ES2955282T3 ES 2955282 T3 ES2955282 T3 ES 2955282T3 ES 18732057 T ES18732057 T ES 18732057T ES 18732057 T ES18732057 T ES 18732057T ES 2955282 T3 ES2955282 T3 ES 2955282T3
- Authority
- ES
- Spain
- Prior art keywords
- heat
- phpl
- platelet lysate
- human platelet
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305739 | 2017-06-16 | ||
| PCT/EP2018/066020 WO2018229278A1 (en) | 2017-06-16 | 2018-06-15 | Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2955282T3 true ES2955282T3 (es) | 2023-11-29 |
Family
ID=59269973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18732057T Active ES2955282T3 (es) | 2017-06-16 | 2018-06-15 | Proceso para preparar un lisado de plaquetas humanas combinadas y su uso para el tratamiento de trastornos neurológicos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11744863B2 (enExample) |
| EP (1) | EP3638263B1 (enExample) |
| JP (1) | JP7370870B2 (enExample) |
| CN (1) | CN110891582A (enExample) |
| AU (1) | AU2018284011B2 (enExample) |
| BR (1) | BR112019026846A2 (enExample) |
| CA (1) | CA3067294A1 (enExample) |
| ES (1) | ES2955282T3 (enExample) |
| IL (1) | IL271436B2 (enExample) |
| WO (1) | WO2018229278A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI744300B (zh) * | 2016-03-23 | 2021-11-01 | 里爾中央醫學中心 | 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途 |
| EP3920944A4 (en) * | 2019-02-07 | 2023-03-29 | Biobridge Global | METHODS AND COMPOSITIONS RELATED TO PLATELET RELEASTAT AND PLATELET-RICH FIBRIN |
| EP3881858A1 (en) * | 2020-03-20 | 2021-09-22 | Rok Pangersic | Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect |
| WO2023103744A1 (zh) * | 2021-12-07 | 2023-06-15 | 无限发展有限公司 | 血小板内生长因子的提取方法 |
| EP4276173A1 (en) | 2022-05-10 | 2023-11-15 | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. | Stable human platelet lysate composition, methods and uses thereof |
| JP2025539432A (ja) * | 2022-12-02 | 2025-12-05 | ナウェーセル バイオテクノロジーズ カンパニー リミテッド | 中脳ドーパミン作動性前駆細胞を成熟させるための培養培地、コーティングマトリックスおよび方法 |
| JP7731557B2 (ja) | 2022-12-30 | 2025-09-01 | スピリット サイエンティフィック カンパニー リミテッド | 血小板含有組成物及びその製造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2006632A6 (es) | 1987-04-21 | 1989-05-01 | Green Cross Corp | Procedimiento de tratamiento termico de fibrinogeno. |
| GB0512401D0 (en) * | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
| WO2008034803A1 (en) * | 2006-09-18 | 2008-03-27 | Medizinische Universität Graz | Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
| EP2077118A1 (en) | 2008-01-07 | 2009-07-08 | Gwo Rei Biomedical Technology Corp. | Clottable concentrate of platelet growth factors and preparation method thereof |
| EP2389942B1 (en) * | 2010-05-25 | 2013-01-23 | GwoWei Technology Co., Ltd. | Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof |
| IL210162A0 (en) * | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
| CN108671224B (zh) * | 2011-06-27 | 2022-12-13 | 爱默蕾大学 | 血小板裂解物的组合物、用途和制备 |
| US20140176602A1 (en) | 2011-08-18 | 2014-06-26 | Nec Corporation | Information processing system, information processing method, information processing apparatus, and control method and control program thereof |
| EP2934603A1 (en) * | 2012-12-20 | 2015-10-28 | Omrix Biopharmaceuticals Ltd. | Viral inactivated biological mixture |
| CN105636599A (zh) * | 2013-08-27 | 2016-06-01 | 库克通用生物技术有限责任公司 | 可来源于血小板浓缩液的生物活性组合物及其制备和使用方法 |
-
2018
- 2018-06-15 EP EP18732057.7A patent/EP3638263B1/en active Active
- 2018-06-15 ES ES18732057T patent/ES2955282T3/es active Active
- 2018-06-15 BR BR112019026846-4A patent/BR112019026846A2/pt unknown
- 2018-06-15 US US16/622,446 patent/US11744863B2/en active Active
- 2018-06-15 CA CA3067294A patent/CA3067294A1/en active Pending
- 2018-06-15 AU AU2018284011A patent/AU2018284011B2/en active Active
- 2018-06-15 WO PCT/EP2018/066020 patent/WO2018229278A1/en not_active Ceased
- 2018-06-15 JP JP2019569741A patent/JP7370870B2/ja active Active
- 2018-06-15 CN CN201880047062.4A patent/CN110891582A/zh active Pending
- 2018-06-15 IL IL271436A patent/IL271436B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110891582A (zh) | 2020-03-17 |
| CA3067294A1 (en) | 2018-12-20 |
| IL271436B1 (en) | 2023-10-01 |
| JP7370870B2 (ja) | 2023-10-30 |
| AU2018284011A1 (en) | 2020-01-16 |
| IL271436B2 (en) | 2024-02-01 |
| US11744863B2 (en) | 2023-09-05 |
| EP3638263A1 (en) | 2020-04-22 |
| BR112019026846A2 (pt) | 2020-06-30 |
| EP3638263C0 (en) | 2023-08-23 |
| IL271436A (en) | 2020-01-30 |
| EP3638263B1 (en) | 2023-08-23 |
| AU2018284011B2 (en) | 2024-05-30 |
| RU2020101295A3 (enExample) | 2022-02-24 |
| US20200113942A1 (en) | 2020-04-16 |
| JP2020523398A (ja) | 2020-08-06 |
| WO2018229278A1 (en) | 2018-12-20 |
| RU2020101295A (ru) | 2021-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2955282T3 (es) | Proceso para preparar un lisado de plaquetas humanas combinadas y su uso para el tratamiento de trastornos neurológicos | |
| ES2980291T3 (es) | Un método para preparar un liberado de plaquetas que contiene factores de crecimiento, y sus usos | |
| AU2017238476B2 (en) | Preparation of platelet pellet lysate and its use for treating neurological disorders | |
| BR112020006316A2 (pt) | processo para preparar uma fração de lisado de plaquetas, fração de lisado de plaquetas e seu uso para tratar transtornos do sistema nervoso central | |
| RU2802440C2 (ru) | Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений | |
| RU2795884C2 (ru) | Способ получения релизата тромбоцитов, содержащего факторы роста | |
| EP4622653A1 (en) | Compositions based on a mixture of bioactive molecules and exosomes for use in the treatment of conditions requiring tissue repair and regeneration |